Myriad Genetics Inc
MYGN- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000899923
No open-market purchases or sales by Myriad Genetics Inc insiders were filed in the last 90 days; 196 institutions reported holding it in 13F filings for Q2 2026, worth $507.8M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Myriad Genetics Inc as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 213
- +14 vs. Q2 2021
- Shares held
- 79.3M
- +4.00M (+5.3%) vs. Q2 2021
- Total value
- $2.56B
- +$258.4M (+11.2%) vs. Q2 2021
- New holders
- 27
- 78 more added
- Sold out
- 13
- 65 more reduced
2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MYGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 196 | $507.8M |
| Q1 2026 | 204 | $519.2M |
| Q4 2025 | 221 | $567.1M |
| Q3 2025 | 221 | $639.8M |
| Q2 2025 | 221 | $480.5M |
| Q1 2025 | 228 | $832.9M |
| Q4 2024 | 221 | $1.27B |
| Q3 2024 | 246 | $2.48B |
| Q2 2024 | 223 | $2.25B |
| Q1 2024 | 186 | $2.00B |
| Q4 2023 | 194 | $1.72B |
| Q3 2023 | 186 | $1.33B |
| Q2 2023 | 188 | $1.88B |
| Q1 2023 | 190 | $1.91B |
| Q4 2022 | 196 | $1.17B |
| Q3 2022 | 191 | $1.55B |
| Q2 2022 | 199 | $1.46B |
| Q1 2022 | 205 | $1.99B |
| Q4 2021 | 197 | $2.16B |
| Q3 2021 | 213 | $2.56B |
| Q2 2021 | 201 | $2.31B |
| Q1 2021 | 197 | $2.25B |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Myriad Genetics Inc; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Disciplined Growth Investors Inc | 1,885,032 | $60.9M | 1.21% | +6,211+0.3% | Added |
| D. E. Shaw & Co., Inc. | 2,008,862 | $64.9M | 0.08% | −233,807−10.4% | Reduced |
| Goldman Sachs Group Inc | 2,131,040 | $68.8M | 0.02% | −83,650−3.8% | Reduced |
| Glenview Capital Management, LLC | 2,235,168 | $72.2M | 1.32% | −240,912−9.7% | Reduced |
| Bank of America Corp | 2,587,125 | $83.5M | 0.01% | +102,611+4.1% | Added |
| Dimensional Fund Advisors LP | 2,686,376 | $86.7M | 0.03% | −82,328−3.0% | Reduced |
| Camber Capital Management LP | 2,750,000 | $88.8M | 3.30% | −250,000−8.3% | Reduced |
| PFM Health Sciences, LP | 2,872,918 | $92.8M | 3.01% | −216,234−7.0% | Reduced |
| Wellington Management Group LLP | 3,231,212 | $104.3M | 0.02% | +2,238,076+225.4% | Added |
| State Street Corp | 4,294,833 | $138.7M | 0.01% | +205,528+5.0% | Added |
| Earnest Partners LLC | 6,251,811 | $201.9M | 1.23% | +58,332+0.9% | Added |
| Vanguard Group Inc | 9,033,197 | $291.7M | 0.01% | +82,377+0.9% | Added |
| BlackRock Inc. | 13,561,305 | $437.9M | 0.01% | −42,365−0.3% | Reduced |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −149,831−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −136,000−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −86,256−100.0% | Sold out |
| SummerHaven Investment Management, LLC | 0 | $0 | 0.00% | −36,725−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −21,200−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −18,036−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −15,023−100.0% | Sold out |
| Eqis Capital Management, Inc. | 0 | $0 | 0.00% | −12,676−100.0% | Sold out |
| Old Mission Capital LLC | 0 | $0 | 0.00% | −10,463−100.0% | Sold out |
| Vident Investment Advisory, LLC | 0 | $0 | 0.00% | −6,689−100.0% | Sold out |
| Parisi Gray Wealth Management | 0 | $0 | 0.00% | −4,340−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −1,774−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −1,027−100.0% | Sold out |
| Pictet Asset Management Ltd | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |